【投顾沙龙·贵阳站】风卷医药海，潮起香江湾

Core Viewpoint - The pharmaceutical sector, previously undervalued, is experiencing a resurgence, particularly in the innovative drug segment, which is becoming a vibrant example of "reverse growth" as of the first half of 2025 [1]. Group 1: Event Details - An insightful seminar on the future of Hong Kong's pharmaceutical industry is scheduled for August 7, 2025, in Guiyang, focusing on the cyclical logic and growth opportunities of innovative drugs [2]. - The seminar will take place at the Guanshan Hall, Hilton Hotel, Guiyang, from 13:30 to 16:00 [3]. Group 2: Seminar Themes and Speakers - The seminar will feature a presentation by Nie Lili, a senior analyst from Guolian Securities, discussing the causes and sustainability of the current innovative drug boom [4]. - Tang Yibing, a fund manager from Bosera Fund, will share insights on investment opportunities in Hong Kong's innovative drug sector, exploring the valuation recovery and ETF allocation logic [4]. - Xiao Peng, the general manager of Guotai Haitong Securities in Guiyang, will provide insights on becoming a versatile investment advisor, sharing pathways for skill enhancement based on personal experience [4].